CANAKINUMAB

CANAKINUMAB was reported 10910 times

CANAKINUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MEVALONATE KINASE DEFICIENCY 8 0.8889
1 FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 16 0.8889
2 MUCKLE-WELLS SYNDROME 40 0.8163
3 X-LINKED LYMPHOPROLIFERATIVE SYNDROME 24 0.7273
4 BRONCHIAL ATRESIA 5 0.7143
5 ACTINOMYCOTIC SEPSIS 17 0.6800
6 CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME 13 0.6500
7 HYPER IGD SYNDROME 9 0.6000
8 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 108 0.5510
9 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 27 0.4500
10 FAMILIAL MEDITERRANEAN FEVER 82 0.4184
11 CHEMOKINE INCREASED 11 0.4074
12 SERUM AMYLOID A PROTEIN INCREASED 53 0.3419
13 VASCULAR COGNITIVE IMPAIRMENT 5 0.2273
14 AUTOINFLAMMATORY DISEASE 47 0.2217
15 INTESTINAL SEPSIS 50 0.1908
16 SHORT STATURE 49 0.1870
17 FAMILIAL AMYLOIDOSIS 4 0.1818
18 PERICARDIAL CALCIFICATION 7 0.1400
19 PERIODONTAL INFLAMMATION 5 0.1316
20 INTERLEUKIN LEVEL INCREASED 66 0.1196
21 HERPES ZOSTER INFECTION NEUROLOGICAL 16 0.1006
22 SPINAL INSTABILITY 25 0.0984
23 APPARENT DEATH 325 0.0902
24 PULMONARY SEPTAL THICKENING 8 0.0899
25 CLUBBING 34 0.0833
26 VEXAS SYNDROME 8 0.0833
27 ATLANTOAXIAL INSTABILITY 9 0.0811
28 SECONDARY AMYLOIDOSIS 12 0.0795
29 PNEUMONIA LIPOID 10 0.0730
30 HYPERTENSIVE CARDIOMYOPATHY 19 0.0683
31 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 8 0.0667
32 JUVENILE IDIOPATHIC ARTHRITIS 156 0.0637
33 HYPERFERRITINAEMIA 24 0.0557
34 EPIDURAL LIPOMATOSIS 19 0.0552
35 PLEURAL ADHESION 9 0.0450
36 MUSCLE ABSCESS 27 0.0433
37 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 297 0.0395
38 CONGENITAL APLASIA 12 0.0386
39 CELLULITIS STAPHYLOCOCCAL 24 0.0369
40 HLA MARKER STUDY POSITIVE 6 0.0366
41 JOINT ARTHROPLASTY 61 0.0340
42 ASTEATOSIS 4 0.0339
43 GROWTH FAILURE 11 0.0320
44 FOCAL NODULAR HYPERPLASIA 16 0.0308
45 STEROID DEPENDENCE 26 0.0296
46 GROWTH RETARDATION 85 0.0288
47 SECONDARY ADRENOCORTICAL INSUFFICIENCY 42 0.0278
48 C-REACTIVE PROTEIN ABNORMAL 167 0.0260
49 PNEUMONIA STREPTOCOCCAL 28 0.0255
50 ALVEOLAR PROTEINOSIS 15 0.0253
51 SCARLET FEVER 8 0.0251
52 HISTIOCYTOSIS HAEMATOPHAGIC 74 0.0249
53 BLOOD CREATINE PHOSPHOKINASE DECREASED 8 0.0244
54 DELAYED PUBERTY 6 0.0236
55 CUSHINGOID 75 0.0233
56 RED BLOOD CELL SEDIMENTATION RATE INCREASED 257 0.0232
57 TERMINAL STATE 152 0.0227
58 RED BLOOD CELL SEDIMENTATION RATE 6 0.0215
59 EXTRAVASATION BLOOD 5 0.0210
60 PULMONARY THROMBOSIS 211 0.0193
61 UPPER RESPIRATORY TRACT INFLAMMATION 22 0.0183
62 CYSTITIS VIRAL 7 0.0183
63 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0181
64 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1242 0.0174
65 CHONDROCALCINOSIS 11 0.0168
66 SPONDYLOARTHROPATHY 10 0.0167
67 SERUM FERRITIN INCREASED 85 0.0161
68 JUVENILE ARTHRITIS 5 0.0152
69 OBSTRUCTIVE SLEEP APNOEA SYNDROME 22 0.0151
70 HYPERPLASIA 13 0.0144
71 COR PULMONALE ACUTE 4 0.0143
72 JOINT ANKYLOSIS 8 0.0141
73 AMYLOIDOSIS 24 0.0139
74 SUPERINFECTION BACTERIAL 11 0.0139
75 DIVERTICULITIS 381 0.0137
76 CUTANEOUS SYMPTOM 9 0.0132
77 STEATOHEPATITIS 7 0.0131
78 WRIST DEFORMITY 8 0.0130
79 OBLITERATIVE BRONCHIOLITIS 16 0.0122
80 VARICELLA ZOSTER VIRUS INFECTION 25 0.0120
81 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 5 0.0119
82 PNEUMONIA MYCOPLASMAL 9 0.0113
83 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 26 0.0113
84 LYMPHANGITIS 9 0.0112
85 ADENOIDAL HYPERTROPHY 4 0.0106
86 INFECTION REACTIVATION 12 0.0105
87 HEPATOSPLENOMEGALY 26 0.0101
88 MENINGITIS LISTERIA 5 0.0098
89 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 20 0.0094
90 CONCOMITANT DISEASE AGGRAVATED 57 0.0092
91 PRODUCT TEMPERATURE EXCURSION ISSUE 47 0.0091
92 SPUTUM ABNORMAL 6 0.0090
93 ILEAL ULCER 9 0.0089
94 C-REACTIVE PROTEIN INCREASED 321 0.0088
95 ROTAVIRUS INFECTION 5 0.0087
96 INFLAMMATORY MARKER INCREASED 42 0.0085
97 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 11 0.0084
98 SKIN OEDEMA 8 0.0080
99 TONSILLITIS 41 0.0078
100 SMALL INTESTINE ULCER 5 0.0077
101 CONCOMITANT DISEASE PROGRESSION 15 0.0077
102 VITILIGO 18 0.0077
103 GENE MUTATION 15 0.0076
104 INTESTINAL DILATATION 10 0.0075
105 STENT PLACEMENT 60 0.0074
106 IMPETIGO 11 0.0074
107 EPIGLOTTITIS 4 0.0074
108 PRODUCT SUPPLY ISSUE 52 0.0073
109 PULMONARY VENO-OCCLUSIVE DISEASE 5 0.0071
110 PHOTOSENSITIVITY REACTION 117 0.0071
111 BLOOD FIBRINOGEN DECREASED 8 0.0070
112 OTITIS MEDIA 23 0.0070
113 SYSTEMIC MYCOSIS 8 0.0068
114 SYMPTOM RECURRENCE 41 0.0068
115 OTITIS MEDIA ACUTE 5 0.0068
116 ANAEMIA OF CHRONIC DISEASE 6 0.0066
117 PULMONARY FUNCTION TEST ABNORMAL 10 0.0064
118 CARDIAC AMYLOIDOSIS 7 0.0064
119 CHOLESTATIC LIVER INJURY 14 0.0063
120 DACTYLITIS 6 0.0061
121 AUTOIMMUNE THYROIDITIS 23 0.0061
122 HAND-FOOT-AND-MOUTH DISEASE 5 0.0060
123 PNEUMONIA VIRAL 19 0.0060
124 NEPHROCALCINOSIS 7 0.0059
125 GRAFT VERSUS HOST DISEASE IN SKIN 13 0.0059
126 VARICELLA 14 0.0059
127 INFECTIOUS MONONUCLEOSIS 13 0.0058
128 NON-ALCOHOLIC STEATOHEPATITIS 6 0.0058
129 ENTEROVIRUS INFECTION 5 0.0058
130 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 16 0.0058
131 RHINOVIRUS INFECTION 22 0.0056
132 ARTHRITIS INFECTIVE 26 0.0056
133 BRONCHIAL WALL THICKENING 4 0.0056
134 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 966 0.0054
135 OSTEOPOROTIC FRACTURE 10 0.0052
136 BACTERIAL SEPSIS 17 0.0052
137 DEEP VEIN THROMBOSIS 337 0.0052
138 PHARYNGITIS STREPTOCOCCAL 55 0.0051
139 INTERSTITIAL LUNG DISEASE 246 0.0051
140 FAECAL CALPROTECTIN INCREASED 16 0.0050
141 BLOOD IMMUNOGLOBULIN G INCREASED 6 0.0049
142 LUNG OPACITY 13 0.0049
143 SPINAL STENOSIS 20 0.0048
144 GASTRIC DILATATION 8 0.0048
145 VEIN DISORDER 24 0.0048
146 TONSILLAR HYPERTROPHY 8 0.0048
147 POLYARTHRITIS 25 0.0047
148 KNEE DEFORMITY 7 0.0047
149 IMMUNE THROMBOCYTOPENIA 21 0.0046
150 INFECTION SUSCEPTIBILITY INCREASED 10 0.0046
151 PSEUDOMONAL SEPSIS 8 0.0046
152 BLOOD ALBUMIN INCREASED 4 0.0045
153 BONE CYST 4 0.0043
154 NORMAL NEWBORN 23 0.0042
155 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 16 0.0042
156 GASTROENTERITIS 61 0.0042
157 SUBCUTANEOUS ABSCESS 20 0.0042
158 PYREXIA 1442 0.0042
159 ADRENAL DISORDER 8 0.0042
160 STREPTOCOCCAL INFECTION 23 0.0041
161 ENTERITIS INFECTIOUS 7 0.0041
162 PULMONARY EMBOLISM 391 0.0041
163 CONTRAINDICATED PRODUCT ADMINISTERED 124 0.0041
164 INFLAMMATORY BOWEL DISEASE 40 0.0041
165 JOINT SWELLING 492 0.0041
166 TYPE IV HYPERSENSITIVITY REACTION 11 0.0040
167 EPSTEIN-BARR VIRUS INFECTION 25 0.0040
168 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0040
169 BUTTERFLY RASH 4 0.0039
170 HEPATIC STEATOSIS 73 0.0039
171 PYODERMA GANGRENOSUM 14 0.0039
172 JOINT EFFUSION 26 0.0038
173 ALLERGY TO ANIMAL 4 0.0038
174 INCORRECT DOSE ADMINISTERED BY PRODUCT 6 0.0037
175 WRONG DOSE 9 0.0037
176 LYMPHADENITIS 9 0.0037
177 HAND FRACTURE 26 0.0037
178 NASAL DISCHARGE DISCOLOURATION 5 0.0036
179 DISCHARGE 5 0.0036
180 OESOPHAGEAL CANDIDIASIS 14 0.0035
181 PHYSICAL DECONDITIONING 9 0.0035
182 OSTEOPENIA 53 0.0035
183 KIDNEY FIBROSIS 6 0.0035
184 SARS-COV-2 TEST POSITIVE 45 0.0034
185 BONE EROSION 12 0.0034
186 CAPILLARY LEAK SYNDROME 7 0.0034
187 CREPITATIONS 10 0.0034
188 BLOOD LACTATE DEHYDROGENASE INCREASED 53 0.0033
189 ATYPICAL PNEUMONIA 10 0.0033
190 ENTEROCOLITIS 19 0.0033
191 SINUS NODE DYSFUNCTION 6 0.0033
192 HEPATOMEGALY 32 0.0033
193 INFLAMMATION 168 0.0033
194 ARTHROPOD BITE 24 0.0032
195 LYMPHADENOPATHY 113 0.0032
196 HERPES ZOSTER 180 0.0031
197 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
198 SPLENOMEGALY 36 0.0031
199 EXPOSURE VIA FATHER 4 0.0031
200 CYTOMEGALOVIRUS COLITIS 7 0.0030
201 DEAFNESS NEUROSENSORY 10 0.0030
202 KNEE ARTHROPLASTY 64 0.0030
203 BODY TEMPERATURE INCREASED 62 0.0030
204 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 78 0.0030
205 CYTOPENIA 37 0.0030
206 CYTOMEGALOVIRUS INFECTION REACTIVATION 13 0.0029
207 WOUND INFECTION 32 0.0029
208 FAILURE TO THRIVE 15 0.0029
209 CONDITION AGGRAVATED 876 0.0029
210 HYPERTRANSAMINASAEMIA 20 0.0029
211 THROMBOSIS 231 0.0029
212 INTRACRANIAL PRESSURE INCREASED 16 0.0029
213 RENAL FAILURE 380 0.0029
214 PHARYNGEAL ERYTHEMA 6 0.0028
215 NEUTROPHIL COUNT ABNORMAL 8 0.0028
216 ATYPICAL MYCOBACTERIAL INFECTION 4 0.0028
217 FIBRIN D DIMER INCREASED 10 0.0028
218 RESPIRATORY SYMPTOM 8 0.0028
219 ILLNESS 289 0.0028
220 SEPSIS 308 0.0028
221 SKIN PAPILLOMA 11 0.0027
222 CUTANEOUS VASCULITIS 10 0.0027
223 VIRAL INFECTION 91 0.0027
224 CONJUNCTIVITIS ALLERGIC 4 0.0027
225 PLEURISY 16 0.0027
226 BK VIRUS INFECTION 9 0.0027
227 IDIOPATHIC INTRACRANIAL HYPERTENSION 6 0.0027
228 PHARYNGITIS 33 0.0027
229 CHRONIC GASTRITIS 6 0.0027
230 ASTIGMATISM 4 0.0026
231 ARTHROPATHY 146 0.0026
232 EAR INFECTION 69 0.0026
233 CORONAVIRUS INFECTION 17 0.0026
234 STOMATITIS 155 0.0026
235 DECREASED IMMUNE RESPONSIVENESS 25 0.0025
236 MULTI-ORGAN DISORDER 5 0.0025
237 MACULE 7 0.0025
238 PARONYCHIA 11 0.0025
239 CELLULITIS 126 0.0025
240 PULMONARY HYPERTENSION 51 0.0024
241 PAPILLOEDEMA 11 0.0024
242 GASTROINTESTINAL PERFORATION 10 0.0024
243 PNEUMOCYSTIS JIROVECII PNEUMONIA 24 0.0024
244 UPPER RESPIRATORY TRACT INFECTION 110 0.0024
245 ALANINE AMINOTRANSFERASE ABNORMAL 5 0.0024
246 ARTHRITIS 184 0.0023
247 ACUTE SINUSITIS 4 0.0023
248 SKIN INFECTION 26 0.0023
249 DEPRESSION SUICIDAL 8 0.0023
250 MENINGITIS 15 0.0022
251 INCORRECT DOSE ADMINISTERED 506 0.0022
252 LOSS OF THERAPEUTIC RESPONSE 7 0.0022
253 OSTEOPOROSIS 90 0.0022
254 RHINORRHOEA 140 0.0022
255 SYNOVIAL CYST 10 0.0022
256 BREAKTHROUGH PAIN 5 0.0022
257 PUSTULE 5 0.0021
258 RHINITIS 17 0.0021
259 ANXIETY DISORDER 7 0.0021
260 LYMPHOCYTE COUNT DECREASED 37 0.0021
261 PERICARDITIS 35 0.0021
262 ADENOVIRUS INFECTION 6 0.0021
263 PANNICULITIS 5 0.0021
264 INFLUENZA 229 0.0021
265 THERAPY PARTIAL RESPONDER 32 0.0020
266 PRODUCT DISTRIBUTION ISSUE 19 0.0020
267 ANAL ABSCESS 11 0.0020
268 BODY TEMPERATURE DECREASED 20 0.0020
269 EMPYEMA 4 0.0020
270 HEPATIC CYTOLYSIS 25 0.0020
271 INJECTION SITE EXTRAVASATION 24 0.0019
272 STAPHYLOCOCCAL INFECTION 64 0.0019
273 GASTROENTERITIS VIRAL 35 0.0019
274 LUNG DISORDER 95 0.0019
275 IMMUNOSUPPRESSION 17 0.0019
276 SARCOIDOSIS 9 0.0019
277 VIRAL UPPER RESPIRATORY TRACT INFECTION 9 0.0019
278 TRANSAMINASES INCREASED 42 0.0019
279 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
280 DISEASE RECURRENCE 89 0.0019
281 DRUG RESISTANCE 48 0.0019
282 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
283 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 102 0.0019
284 MOUTH ULCERATION 39 0.0018
285 INTENTIONAL PRODUCT USE ISSUE 161 0.0018
286 SUSPECTED COVID-19 6 0.0018
287 URTICARIA 303 0.0018
288 PROCTITIS 5 0.0018
289 MENINGITIS ASEPTIC 8 0.0018
290 CONJUNCTIVITIS 33 0.0018
291 COVID-19 312 0.0018
292 POSTOPERATIVE WOUND INFECTION 12 0.0018
293 UVEITIS 24 0.0018
294 NASAL CONGESTION 102 0.0017
295 ANGINA UNSTABLE 11 0.0017
296 OCULAR DISCOMFORT 19 0.0017
297 FOOT FRACTURE 32 0.0017
298 CONJUNCTIVAL HYPERAEMIA 6 0.0017
299 EYE INFLAMMATION 16 0.0017
300 APHTHOUS ULCER 13 0.0017
301 MALAISE 731 0.0017
302 DRUG INTOLERANCE 160 0.0017
303 BONE MARROW DISORDER 5 0.0017
304 HIDRADENITIS 15 0.0016
305 QUALITY OF LIFE DECREASED 22 0.0016
306 AUTISM SPECTRUM DISORDER 9 0.0016
307 PARADOXICAL DRUG REACTION 6 0.0016
308 ABSCESS 26 0.0016
309 MULTIPLE-DRUG RESISTANCE 5 0.0016
310 CARDIAC DYSFUNCTION 6 0.0016
311 HAEMOGLOBIN DECREASED 165 0.0016
312 SPINAL FRACTURE 32 0.0016
313 ERYSIPELAS 8 0.0016
314 BLOOD PRESSURE SYSTOLIC INCREASED 31 0.0016
315 OROPHARYNGEAL PAIN 146 0.0016
316 RHINITIS ALLERGIC 7 0.0016
317 EOSINOPHIL COUNT INCREASED 13 0.0016
318 EOSINOPHILIA 27 0.0015
319 PAIN 946 0.0015
320 WOUND SECRETION 6 0.0015
321 SKIN LESION 42 0.0015
322 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
323 NEAR DEATH EXPERIENCE 5 0.0015
324 UTERINE LEIOMYOMA 11 0.0015
325 LYME DISEASE 5 0.0015
326 DEAFNESS 39 0.0015
327 SPINAL DISORDER 14 0.0015
328 ARTHRALGIA 613 0.0015
329 TOOTH ABSCESS 15 0.0015
330 HYDRONEPHROSIS 11 0.0015
331 THERAPY NON-RESPONDER 66 0.0015
332 HYPERURICAEMIA 6 0.0015
333 INFECTION 211 0.0015
334 ACUTE CORONARY SYNDROME 12 0.0014
335 OBESITY 23 0.0014
336 EAR PAIN 28 0.0014
337 NEURALGIA 35 0.0014
338 AUTOIMMUNE DISORDER 14 0.0014
339 PRODUCT LEAKAGE 8 0.0014
340 RESPIRATORY TRACT INFECTION 37 0.0014
341 BREATH SOUNDS ABNORMAL 7 0.0014
342 PAPULE 10 0.0014
343 IMMUNODEFICIENCY 21 0.0014
344 NEUTROPHILIA 8 0.0014
345 ENTERITIS 9 0.0014
346 PSEUDOMONAS INFECTION 12 0.0014
347 MYOCARDITIS 16 0.0014
348 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10 0.0014
349 APPENDICITIS 13 0.0014
350 SPONDYLITIS 5 0.0014
351 HYPOGAMMAGLOBULINAEMIA 9 0.0014
352 PRODUCT USE IN UNAPPROVED INDICATION 337 0.0014
353 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
354 ILEUS PARALYTIC 6 0.0013
355 NASOPHARYNGITIS 247 0.0013
356 SCRATCH 14 0.0013
357 PRODUCT STORAGE ERROR 116 0.0013
358 INJECTION SITE VESICLES 8 0.0013
359 ADRENAL INSUFFICIENCY 16 0.0013
360 TROPONIN INCREASED 10 0.0013
361 SYRINGE ISSUE 23 0.0013
362 RASH 571 0.0013
363 SKIN PLAQUE 11 0.0013
364 DUODENITIS 4 0.0013
365 HAEMOLYSIS 10 0.0013
366 BRONCHOPULMONARY ASPERGILLOSIS 10 0.0013
367 INFUSION SITE EXTRAVASATION 8 0.0013
368 LOCALISED INFECTION 31 0.0013
369 PRODUCT AVAILABILITY ISSUE 29 0.0013
370 NEEDLE ISSUE 37 0.0013
371 OSTEOMYELITIS 23 0.0013
372 PYELONEPHRITIS 11 0.0013
373 BRAIN OEDEMA 16 0.0013
374 ABDOMINAL PAIN 288 0.0012
375 RESPIRATORY DISORDER 37 0.0012
376 THERAPEUTIC RESPONSE SHORTENED 41 0.0012
377 HEPATITIS ACUTE 8 0.0012
378 DEMYELINATION 5 0.0012
379 ILL-DEFINED DISORDER 74 0.0012
380 WOUND 34 0.0012
381 STAPHYLOCOCCAL SEPSIS 6 0.0012
382 ANAPHYLACTOID REACTION 5 0.0012
383 FRACTURE 23 0.0012
384 INJECTION SITE INFLAMMATION 6 0.0012
385 SKIN WARM 7 0.0012
386 FLUID INTAKE REDUCED 6 0.0012
387 PNEUMONIA BACTERIAL 11 0.0012
388 HYPERTRIGLYCERIDAEMIA 7 0.0012
389 COUGH 335 0.0012
390 ATRIAL SEPTAL DEFECT 10 0.0012
391 PRODUCT ADMINISTRATION ERROR 24 0.0012
392 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
393 BRONCHIECTASIS 8 0.0012
394 ACUTE RESPIRATORY DISTRESS SYNDROME 21 0.0012
395 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
396 DRUG DISPENSING ERROR 18 0.0012
397 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
398 ABSCESS LIMB 5 0.0012
399 LIVER FUNCTION TEST INCREASED 25 0.0012
400 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
401 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
402 SENSITIVITY TO WEATHER CHANGE 6 0.0011
403 SKIN DISORDER 38 0.0011
404 BRONCHIOLITIS 4 0.0011
405 PRODUCT PRESCRIBING ERROR 27 0.0011
406 ABDOMINAL ABSCESS 5 0.0011
407 LYMPHOPENIA 16 0.0011
408 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
409 BLOOD DISORDER 9 0.0011
410 RENAL TUBULAR NECROSIS 11 0.0011
411 FOOD POISONING 6 0.0011
412 GASTROINTESTINAL INFECTION 10 0.0011
413 GINGIVITIS 6 0.0011
414 EAR DISORDER 5 0.0011
415 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
416 IRON DEFICIENCY ANAEMIA 10 0.0011
417 PERICARDIAL EFFUSION 25 0.0011
418 BRONCHITIS 80 0.0011
419 LEUKOPENIA 54 0.0011
420 INTERCEPTED MEDICATION ERROR 5 0.0011
421 BACTERIAL INFECTION 20 0.0011
422 IMMUNE SYSTEM DISORDER 14 0.0011
423 HEPATIC ENZYME INCREASED 72 0.0011
424 TENDERNESS 11 0.0011
425 PNEUMONIA 338 0.0010
426 INJECTION SITE RASH 32 0.0010
427 JOINT DISLOCATION 11 0.0010
428 SKIN SWELLING 9 0.0010
429 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
430 RALES 6 0.0010
431 THROMBOTIC MICROANGIOPATHY 10 0.0010
432 ALANINE AMINOTRANSFERASE INCREASED 63 0.0010
433 CATARACT 61 0.0010
434 INCORRECT DOSAGE ADMINISTERED 5 0.0010
435 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
436 LIGAMENT SPRAIN 10 0.0010
437 LOW BIRTH WEIGHT BABY 8 0.0010
438 ODYNOPHAGIA 6 0.0010
439 CEREBRAL ATROPHY 4 0.0010
440 MATERNAL EXPOSURE DURING PREGNANCY 89 0.0010
441 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
442 HEPATITIS 25 0.0010
443 NEUTROPHIL COUNT INCREASED 10 0.0010
444 CARDIOMEGALY 12 0.0010
445 ENDOCARDITIS 5 0.0010
446 ARTHRITIS BACTERIAL 4 0.0010
447 HYPOKINESIA 14 0.0010
448 PRODUCT DISPENSING ERROR 21 0.0010
449 PRODUCTIVE COUGH 46 0.0010
450 MYOCARDIAL INFARCTION 168 0.0010
451 FEELING ABNORMAL 228 0.0010
452 DRUG INEFFECTIVE 1242 0.0009
453 RASH ERYTHEMATOUS 45 0.0009
454 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
455 NECK PAIN 52 0.0009
456 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
457 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 65 0.0009
458 DEAFNESS UNILATERAL 5 0.0009
459 HAEMATOCHEZIA 50 0.0009
460 DENTAL CARIES 10 0.0009
461 BLOOD CREATINE INCREASED 4 0.0009
462 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
463 GASTROINTESTINAL DISORDER 79 0.0009
464 CHILLS 103 0.0009
465 DISEASE COMPLICATION 4 0.0009
466 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
467 LARGE INTESTINE PERFORATION 6 0.0009
468 OCULAR HYPERAEMIA 41 0.0009
469 AUTOIMMUNE HEPATITIS 6 0.0009
470 OFF LABEL USE 751 0.0009
471 TREATMENT FAILURE 71 0.0009
472 FLANK PAIN 8 0.0009
473 HEPATIC CIRRHOSIS 16 0.0009
474 ESCHERICHIA INFECTION 7 0.0009
475 PALLOR 23 0.0008
476 PLATELET COUNT INCREASED 11 0.0008
477 CYTOMEGALOVIRUS INFECTION 14 0.0008
478 FEAR OF INJECTION 6 0.0008
479 COAGULOPATHY 14 0.0008
480 IMPAIRED QUALITY OF LIFE 12 0.0008
481 GLAUCOMA 16 0.0008
482 HEART RATE DECREASED 29 0.0008
483 MELAENA 18 0.0008
484 COLITIS 31 0.0008
485 MYALGIA 139 0.0008
486 HEPATOTOXICITY 18 0.0008
487 PNEUMONITIS 22 0.0008
488 GENERALISED OEDEMA 10 0.0008
489 SCOLIOSIS 5 0.0008
490 NIGHT SWEATS 26 0.0008
491 INTESTINAL PERFORATION 9 0.0008
492 NEPHROPATHY TOXIC 9 0.0008
493 INCORRECT DOSE ADMINISTERED BY DEVICE 21 0.0008
494 NAIL DISORDER 7 0.0008
495 SECRETION DISCHARGE 10 0.0008
496 BLEPHAROSPASM 5 0.0008
497 PURPURA 7 0.0008
498 HYPOMAGNESAEMIA 11 0.0008
499 RESPIRATORY RATE INCREASED 7 0.0008
500 FACIAL PAIN 7 0.0008
501 SKIN REACTION 11 0.0008
502 HEPATOCELLULAR INJURY 11 0.0008
503 CONCUSSION 6 0.0008
504 VASCULITIS 9 0.0008
505 PERITONITIS 16 0.0008
506 HERPES SIMPLEX 5 0.0008
507 FOLLICULITIS 8 0.0008
508 COVID-19 PNEUMONIA 9 0.0008
509 HYPERTENSION 161 0.0008
510 BACTERAEMIA 9 0.0008
511 FURUNCLE 6 0.0008
512 CHOLECYSTITIS 9 0.0008
513 GINGIVAL PAIN 6 0.0008
514 SINUSITIS 77 0.0008
515 HEPATIC FUNCTION ABNORMAL 28 0.0007
516 JOINT INJURY 16 0.0007
517 ASCITES 22 0.0007
518 GAIT INABILITY 25 0.0007
519 SWELLING 70 0.0007
520 LIVER DISORDER 33 0.0007
521 DISEASE PROGRESSION 88 0.0007
522 HYPOACUSIS 32 0.0007
523 THROMBOCYTOPENIA 83 0.0007
524 DECREASED ACTIVITY 8 0.0007
525 PROTEINURIA 14 0.0007
526 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
527 INJECTION SITE REACTION 50 0.0007
528 MUSCULOSKELETAL STIFFNESS 63 0.0007
529 ORAL HERPES 14 0.0007
530 APHONIA 10 0.0007
531 PHARYNGEAL SWELLING 7 0.0007
532 MOBILITY DECREASED 51 0.0007
533 HEADACHE 445 0.0007
534 STATUS EPILEPTICUS 8 0.0007
535 FLUID RETENTION 36 0.0007
536 MUSCULOSKELETAL PAIN 37 0.0007
537 RASH PRURITIC 38 0.0007
538 WEIGHT INCREASED 157 0.0007
539 AGRANULOCYTOSIS 13 0.0007
540 HYPERSOMNIA 20 0.0007
541 HYPOTHERMIA 7 0.0007
542 FEEDING DISORDER 14 0.0007
543 FAECES SOFT 5 0.0007
544 INCORRECT PRODUCT STORAGE 9 0.0007
545 GASTRITIS 18 0.0007
546 TOOTH INFECTION 9 0.0007
547 PAIN IN EXTREMITY 201 0.0007
548 HELICOBACTER INFECTION 7 0.0007
549 ERYTHEMA 140 0.0007
550 THERAPEUTIC RESPONSE DECREASED 41 0.0007
551 PRESCRIBED OVERDOSE 13 0.0007
552 PULMONARY OEDEMA 30 0.0007
553 ANAPHYLACTIC REACTION 37 0.0007
554 MYOSITIS 6 0.0007
555 SEPTIC SHOCK 29 0.0007
556 OROPHARYNGEAL DISCOMFORT 6 0.0007
557 CHEST PAIN 123 0.0007
558 LIMB INJURY 18 0.0007
559 KIDNEY INFECTION 13 0.0007
560 URINARY TRACT INFECTION 113 0.0007
561 RESPIRATORY FAILURE 48 0.0007
562 HYPOTHYROIDISM 21 0.0007
563 VOMITING 308 0.0007
564 HYPERTHERMIA 5 0.0007
565 RETINAL DETACHMENT 6 0.0007
566 CANDIDA INFECTION 11 0.0007
567 UROSEPSIS 6 0.0006
568 MUCOSAL INFLAMMATION 17 0.0006
569 JOINT STIFFNESS 17 0.0006
570 SWELLING FACE 42 0.0006
571 MASS 9 0.0006
572 LETHARGY 37 0.0006
573 HYPOALBUMINAEMIA 5 0.0006
574 DIARRHOEA HAEMORRHAGIC 6 0.0006
575 TACHYCARDIA 57 0.0006
576 GASTROINTESTINAL INFLAMMATION 5 0.0006
577 GASTROINTESTINAL PAIN 7 0.0006
578 LEUKAEMIA 6 0.0006
579 RHEUMATOID ARTHRITIS 72 0.0006
580 SPUTUM DISCOLOURED 6 0.0006
581 PRODUCT USE ISSUE 118 0.0006
582 ABORTION SPONTANEOUS 25 0.0006
583 RENAL DISORDER 29 0.0006
584 ATELECTASIS 6 0.0006
585 DRUG ADMINISTRATION ERROR 19 0.0006
586 BLOOD PRESSURE DECREASED 41 0.0006
587 PRODUCT DOSE OMISSION ISSUE 181 0.0006
588 VITAMIN D DEFICIENCY 6 0.0006
589 POST PROCEDURAL INFECTION 5 0.0006
590 BONE PAIN 36 0.0006
591 NEUTROPHIL COUNT DECREASED 25 0.0006
592 NODULE 8 0.0006
593 LIVER INJURY 15 0.0006
594 ENCEPHALOPATHY 15 0.0006
595 ASPERGILLUS INFECTION 4 0.0006
596 LEUKOCYTOSIS 11 0.0006
597 VERTIGO 37 0.0006
598 CRYING 22 0.0006
599 CARDIAC FAILURE ACUTE 4 0.0006
600 SPINAL PAIN 7 0.0006
601 ABDOMINAL PAIN UPPER 123 0.0006
602 TACHYPNOEA 8 0.0006
603 SLUGGISHNESS 6 0.0006
604 FACIAL PARALYSIS 5 0.0006
605 LYMPHOMA 9 0.0006
606 MUSCULOSKELETAL CHEST PAIN 9 0.0006
607 TEMPERATURE INTOLERANCE 6 0.0006
608 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
609 ORAL PAIN 13 0.0006
610 IMPAIRED HEALING 19 0.0006
611 ENCEPHALITIS 4 0.0006
612 MUSCLE STRAIN 5 0.0006
613 PETECHIAE 6 0.0006
614 NEUTROPENIA 78 0.0006
615 PANCYTOPENIA 32 0.0006
616 CYANOSIS 9 0.0006
617 ACUTE RESPIRATORY FAILURE 11 0.0006
618 INFLUENZA LIKE ILLNESS 47 0.0006
619 GROIN PAIN 5 0.0006
620 LUNG INFILTRATION 5 0.0006
621 RENAL PAIN 6 0.0006
622 HAEMORRHOIDS 11 0.0006
623 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
624 EATING DISORDER 12 0.0006
625 DIVERTICULUM 4 0.0006
626 MOVEMENT DISORDER 18 0.0006
627 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4 0.0006
628 BLOOD BILIRUBIN INCREASED 15 0.0006
629 ECZEMA 29 0.0006
630 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
631 DEVICE DISLOCATION 24 0.0006
632 VENTRICULAR TACHYCARDIA 9 0.0005
633 HYPOXIA 19 0.0005
634 HYPERTENSIVE CRISIS 6 0.0005
635 FEELING COLD 15 0.0005
636 DUODENAL ULCER PERFORATION 4 0.0005
637 MALNUTRITION 6 0.0005
638 SNEEZING 12 0.0005
639 MIGRAINE 51 0.0005
640 BLISTER 30 0.0005
641 ORAL CANDIDIASIS 7 0.0005
642 ARTERIOSCLEROSIS 5 0.0005
643 REBOUND EFFECT 6 0.0005
644 INJECTION SITE URTICARIA 13 0.0005
645 ANAEMIA 101 0.0005
646 SEIZURE 61 0.0005
647 INFUSION RELATED REACTION 35 0.0005
648 PLEURAL EFFUSION 32 0.0005
649 BACK PAIN 121 0.0005
650 GENERAL PHYSICAL HEALTH DETERIORATION 60 0.0005
651 FOOD ALLERGY 4 0.0005
652 OEDEMA 28 0.0005
653 DYSURIA 19 0.0005
654 ABDOMINAL PAIN LOWER 13 0.0005
655 FATIGUE 400 0.0005
656 BASAL CELL CARCINOMA 8 0.0005
657 HYPERHIDROSIS 66 0.0005
658 INJECTION SITE SWELLING 39 0.0005
659 AFFECTIVE DISORDER 4 0.0005
660 FAECES DISCOLOURED 11 0.0005
661 LOWER RESPIRATORY TRACT INFECTION 23 0.0005
662 ACCIDENT 6 0.0005
663 SKIN DISCOLOURATION 23 0.0005
664 BURSITIS 6 0.0005
665 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
666 MOTOR DYSFUNCTION 5 0.0005
667 PARALYSIS 7 0.0005
668 ANGINA PECTORIS 14 0.0005
669 BLOOD CREATINE PHOSPHOKINASE INCREASED 14 0.0005
670 MYELODYSPLASTIC SYNDROME 7 0.0005
671 CYST 6 0.0005
672 JAUNDICE 13 0.0005
673 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
674 PERIPHERAL SWELLING 74 0.0005
675 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
676 WEIGHT FLUCTUATION 5 0.0005
677 FEELING HOT 29 0.0005
678 RESPIRATORY DISTRESS 13 0.0005
679 HYPOPHAGIA 12 0.0005
680 PULMONARY FIBROSIS 9 0.0005
681 FEBRILE NEUTROPENIA 31 0.0005
682 RASH GENERALISED 12 0.0005
683 DIARRHOEA 296 0.0005
684 PULMONARY CONGESTION 6 0.0005
685 DEVICE RELATED INFECTION 7 0.0005
686 MENTAL IMPAIRMENT 11 0.0005
687 PRESYNCOPE 11 0.0005
688 RASH MACULO-PAPULAR 10 0.0004
689 RASH PAPULAR 10 0.0004
690 GOUT 8 0.0004
691 DYSSTASIA 13 0.0004
692 TOOTHACHE 8 0.0004
693 PNEUMOTHORAX 7 0.0004
694 LABORATORY TEST ABNORMAL 13 0.0004
695 ULCER 7 0.0004
696 PREMATURE DELIVERY 7 0.0004
697 INJECTION SITE HAEMORRHAGE 35 0.0004
698 EXOSTOSIS 4 0.0004
699 PERIPHERAL COLDNESS 6 0.0004
700 HYPERSENSITIVITY 81 0.0004
701 MEDICATION ERROR 24 0.0004
702 GAIT DISTURBANCE 82 0.0004
703 BLOOD TEST ABNORMAL 6 0.0004
704 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
705 EYE PAIN 24 0.0004
706 PHOTOPHOBIA 8 0.0004
707 INTESTINAL OBSTRUCTION 16 0.0004
708 SEASONAL ALLERGY 6 0.0004
709 FUNGAL INFECTION 14 0.0004
710 MUSCLE RIGIDITY 5 0.0004
711 BLOOD UREA INCREASED 7 0.0004
712 DRUG PRESCRIBING ERROR 8 0.0004
713 PLATELET COUNT DECREASED 44 0.0004
714 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
715 WEIGHT DECREASED 115 0.0004
716 CIRCULATORY COLLAPSE 7 0.0004
717 NO THERAPEUTIC RESPONSE 5 0.0004
718 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12 0.0004
719 HAEMATURIA 14 0.0004
720 MOOD SWINGS 13 0.0004
721 HAEMATOCRIT DECREASED 8 0.0004
722 PULMONARY MASS 6 0.0004
723 INJECTION SITE BRUISING 32 0.0004
724 AGEUSIA 10 0.0004
725 BRAIN INJURY 4 0.0004
726 DYSPNOEA EXERTIONAL 15 0.0004
727 SUICIDE ATTEMPT 24 0.0004
728 BLOOD COUNT ABNORMAL 6 0.0004
729 INJECTION SITE PAIN 121 0.0004
730 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
731 INSURANCE ISSUE 6 0.0004
732 INJECTION SITE WARMTH 8 0.0004
733 INJECTION SITE PRURITUS 26 0.0004
734 LIMB DISCOMFORT 12 0.0004
735 HAEMATOMA 10 0.0004
736 INJECTION SITE INDURATION 5 0.0004
737 ROAD TRAFFIC ACCIDENT 16 0.0004
738 PRURITUS 145 0.0004
739 DYSMENORRHOEA 5 0.0004
740 ADVERSE REACTION 5 0.0004
741 CYSTITIS 12 0.0004
742 HEART RATE INCREASED 37 0.0004
743 RASH MACULAR 13 0.0004
744 SKIN IRRITATION 17 0.0004
745 DEVICE LEAKAGE 16 0.0004
746 BLOOD URINE PRESENT 7 0.0004
747 PRODUCT PRESCRIBING ISSUE 8 0.0004
748 SLEEP APNOEA SYNDROME 7 0.0004
749 ACUTE KIDNEY INJURY 56 0.0004
750 CHOLELITHIASIS 12 0.0004
751 OSTEONECROSIS 12 0.0004
752 HEPATIC FAILURE 11 0.0004
753 BLOOD PRESSURE INCREASED 55 0.0004
754 CHOKING 7 0.0004
755 UNDERDOSE 26 0.0004
756 EYE INFECTION 4 0.0004
757 WHEEZING 21 0.0004
758 CONTUSION 34 0.0004
759 NERVOUS SYSTEM DISORDER 11 0.0004
760 DEHYDRATION 47 0.0004
761 BLOOD PRESSURE ABNORMAL 7 0.0004
762 ABDOMINAL DISCOMFORT 59 0.0004
763 PRESCRIBED UNDERDOSE 7 0.0004
764 SUBDURAL HAEMATOMA 5 0.0003
765 NEPHROLITHIASIS 16 0.0003
766 MUSCULOSKELETAL DISCOMFORT 6 0.0003
767 CARDIOGENIC SHOCK 5 0.0003
768 ANOSMIA 5 0.0003
769 ABDOMINAL DISTENSION 36 0.0003
770 BURNING SENSATION 24 0.0003
771 ASTHENIA 128 0.0003
772 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
773 CARDIAC FAILURE 27 0.0003
774 COLITIS ULCERATIVE 15 0.0003
775 COLON CANCER 5 0.0003
776 HAEMORRHAGE 35 0.0003
777 SYNOVITIS 6 0.0003
778 CARDIAC DISORDER 31 0.0003
779 LIP SWELLING 11 0.0003
780 OSTEOARTHRITIS 14 0.0003
781 MOOD ALTERED 9 0.0003
782 SYNCOPE 33 0.0003
783 ABNORMAL BEHAVIOUR 13 0.0003
784 DISCOMFORT 20 0.0003
785 EPILEPSY 10 0.0003
786 IRRITABLE BOWEL SYNDROME 7 0.0003
787 ABASIA 8 0.0003
788 ANXIETY 92 0.0003
789 NAUSEA 254 0.0003
790 ACCIDENTAL EXPOSURE TO PRODUCT 33 0.0003
791 SWOLLEN TONGUE 10 0.0003
792 BRAIN FOG 5 0.0003
793 DRUG-INDUCED LIVER INJURY 10 0.0003
794 ACNE 24 0.0003
795 DYSPNOEA 179 0.0003
796 GASTRIC ULCER 6 0.0003
797 INSOMNIA 84 0.0003
798 MUSCULOSKELETAL DISORDER 6 0.0003
799 INCREASED APPETITE 6 0.0003
800 SCIATICA 5 0.0003
801 PANCREATITIS ACUTE 7 0.0003
802 ANAPHYLACTIC SHOCK 8 0.0003
803 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
804 EPISTAXIS 23 0.0003
805 DECREASED APPETITE 71 0.0003
806 SPEECH DISORDER 16 0.0003
807 EYE DISORDER 10 0.0003
808 DRUG EFFECT INCOMPLETE 11 0.0003
809 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
810 UPPER LIMB FRACTURE 6 0.0003
811 PREMATURE BABY 9 0.0003
812 INJECTION SITE ERYTHEMA 37 0.0003
813 FULL BLOOD COUNT DECREASED 6 0.0003
814 ACUTE HEPATIC FAILURE 4 0.0003
815 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
816 PALPITATIONS 34 0.0003
817 DIABETES MELLITUS 22 0.0003
818 FIBROMYALGIA 7 0.0003
819 HAEMOPTYSIS 8 0.0003
820 LOCAL SWELLING 5 0.0003
821 DERMATITIS 6 0.0003
822 METASTASES TO LIVER 5 0.0003
823 PANCREATITIS 15 0.0003
824 COLD SWEAT 5 0.0003
825 HEAD DISCOMFORT 5 0.0003
826 MUSCULAR WEAKNESS 32 0.0003
827 BRONCHOSPASM 4 0.0003
828 CEREBRAL HAEMORRHAGE 10 0.0003
829 DIZZINESS 139 0.0003
830 CARDIOVASCULAR DISORDER 7 0.0003
831 PELVIC PAIN 5 0.0003
832 FLUID OVERLOAD 4 0.0003
833 HYPERGLYCAEMIA 10 0.0003
834 END STAGE RENAL DISEASE 5 0.0003
835 ANGIOEDEMA 12 0.0003
836 INJECTION SITE MASS 10 0.0003
837 URINARY INCONTINENCE 8 0.0003
838 THROAT IRRITATION 12 0.0003
839 OXYGEN SATURATION DECREASED 15 0.0003
840 LOWER LIMB FRACTURE 5 0.0003
841 DELIRIUM 9 0.0003
842 GYNAECOMASTIA 8 0.0003
843 HYPERKALAEMIA 9 0.0003
844 DYSPHONIA 15 0.0003
845 FALL 85 0.0003
846 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
847 IRRITABILITY 15 0.0002
848 CYTOKINE RELEASE SYNDROME 5 0.0002
849 NERVOUSNESS 13 0.0002
850 CONSTIPATION 54 0.0002
851 PAIN IN JAW 7 0.0002
852 BLOOD POTASSIUM INCREASED 4 0.0002
853 BONE MARROW FAILURE 5 0.0002
854 PRODUCT DOSE OMISSION 16 0.0002
855 HYPOTENSION 49 0.0002
856 PRODUCT PREPARATION ERROR 5 0.0002
857 LOSS OF CONSCIOUSNESS 31 0.0002
858 VISUAL ACUITY REDUCED 8 0.0002
859 LIVER FUNCTION TEST ABNORMAL 7 0.0002
860 PNEUMONIA ASPIRATION 6 0.0002
861 HOT FLUSH 18 0.0002
862 WITHDRAWAL SYNDROME 10 0.0002
863 RENAL IMPAIRMENT 20 0.0002
864 OEDEMA PERIPHERAL 29 0.0002
865 FACE OEDEMA 4 0.0002
866 SKIN EXFOLIATION 20 0.0002
867 HAEMATEMESIS 6 0.0002
868 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 47 0.0002
869 LACRIMATION INCREASED 7 0.0002
870 VAGINAL HAEMORRHAGE 10 0.0002
871 MENTAL DISORDER 10 0.0002
872 DEVICE USE ISSUE 4 0.0002
873 DISORIENTATION 9 0.0002
874 HYPOGLYCAEMIA 11 0.0002
875 BRADYCARDIA 12 0.0002
876 EYE IRRITATION 13 0.0002
877 TOOTH DISORDER 5 0.0002
878 CHEST DISCOMFORT 23 0.0002
879 PAIN OF SKIN 6 0.0002
880 DRUG EFFECT DECREASED 12 0.0002
881 HEART RATE IRREGULAR 5 0.0002
882 BONE DISORDER 4 0.0002
883 ALOPECIA 43 0.0002
884 VISUAL IMPAIRMENT 27 0.0002
885 TINNITUS 10 0.0002
886 HIP FRACTURE 7 0.0002
887 SHOCK 5 0.0002
888 ADVERSE EVENT 20 0.0002
889 MENTAL STATUS CHANGES 6 0.0002
890 ATRIAL FIBRILLATION 21 0.0002
891 EYE SWELLING 8 0.0002
892 BLOOD CHOLESTEROL INCREASED 10 0.0002
893 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
894 ASTHMA 24 0.0002
895 ARRHYTHMIA 10 0.0002
896 RED BLOOD CELL COUNT DECREASED 6 0.0002
897 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
898 ANGER 7 0.0002
899 BLOOD CREATININE INCREASED 13 0.0002
900 SLEEP DISORDER 14 0.0002
901 PSORIATIC ARTHROPATHY 8 0.0002
902 FLUSHING 20 0.0002
903 BLINDNESS 8 0.0002
904 NEOPLASM MALIGNANT 13 0.0002
905 EMOTIONAL DISORDER 6 0.0002
906 DEPRESSION 44 0.0002
907 RHABDOMYOLYSIS 8 0.0002
908 DEATH 165 0.0002
909 CARDIO-RESPIRATORY ARREST 8 0.0002
910 HEAD INJURY 6 0.0002
911 NO ADVERSE EVENT 34 0.0002
912 METABOLIC ACIDOSIS 6 0.0002
913 HYPOAESTHESIA 28 0.0002
914 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
915 PARAESTHESIA 29 0.0002
916 PSORIASIS 24 0.0002
917 DEMENTIA 5 0.0002
918 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
919 TYPE 2 DIABETES MELLITUS 6 0.0002
920 ADVERSE DRUG REACTION 16 0.0002
921 TOXICITY TO VARIOUS AGENTS 30 0.0002
922 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
923 COMA 8 0.0002
924 THERAPY INTERRUPTED 12 0.0002
925 BLOOD PRESSURE FLUCTUATION 4 0.0002
926 DIABETIC KETOACIDOSIS 4 0.0002
927 BLOOD POTASSIUM DECREASED 5 0.0002
928 CORONARY ARTERY DISEASE 5 0.0002
929 PANIC ATTACK 6 0.0002
930 RECTAL HAEMORRHAGE 7 0.0002
931 DYSPHAGIA 15 0.0002
932 MUSCLE SPASMS 29 0.0002
933 DEVICE ISSUE 14 0.0002
934 SUICIDAL IDEATION 14 0.0002
935 DERMATITIS ATOPIC 8 0.0002
936 DEPRESSED MOOD 8 0.0002
937 BALANCE DISORDER 13 0.0002
938 URINARY RETENTION 5 0.0001
939 AGITATION 11 0.0001
940 DYSKINESIA 6 0.0001
941 CEREBROVASCULAR ACCIDENT 25 0.0001
942 LUNG NEOPLASM MALIGNANT 6 0.0001
943 CARDIAC ARREST 12 0.0001
944 DYSPEPSIA 14 0.0001
945 SOMNOLENCE 28 0.0001
946 VISION BLURRED 19 0.0001
947 AMNESIA 9 0.0001
948 HOSPITALISATION 21 0.0001
949 THERAPY CESSATION 7 0.0001
950 DYSARTHRIA 5 0.0001
951 TREMOR 22 0.0001
952 APHASIA 4 0.0001
953 HYPOKALAEMIA 6 0.0001
954 FEMUR FRACTURE 4 0.0001
955 TREATMENT NONCOMPLIANCE 7 0.0001
956 CONVULSION 7 0.0001
957 POLLAKIURIA 5 0.0001
958 OVERDOSE 25 0.0001
959 DEVICE MALFUNCTION 8 0.0001
960 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
961 DRUG INTERACTION 16 0.0001
962 EXTRA DOSE ADMINISTERED 4 0.0001
963 DRY MOUTH 8 0.0001
964 DRY SKIN 13 0.0001
965 BREAST CANCER 9 0.0001
966 CHRONIC KIDNEY DISEASE 7 0.0001
967 MEMORY IMPAIRMENT 12 0.0001
968 CARDIAC FAILURE CONGESTIVE 7 0.0001
969 COGNITIVE DISORDER 4 0.0001
970 BLOOD GLUCOSE INCREASED 16 0.0001
971 NEUROPATHY PERIPHERAL 8 0.0001
972 BLOOD GLUCOSE DECREASED 4 0.0001
973 EXPOSURE DURING PREGNANCY 5 0.0001
974 HALLUCINATION 6 0.0001
975 INJURY 5 0.0001
976 DYSGEUSIA 5 0.0001
977 PRODUCT QUALITY ISSUE 9 0.0001
978 UNEVALUABLE EVENT 5 0.0001
979 DRUG DOSE OMISSION BY DEVICE 5 0.0001
980 DRUG DEPENDENCE 10 0.0001
981 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
982 DRUG DOSE OMISSION 7 0.0000
983 EMOTIONAL DISTRESS 5 0.0000
984 CONFUSIONAL STATE 5 0.0000